|
A more recent version of this article appeared on October 12, 2007
Papers In Press, published online ahead of print August 20, 2007
J. Biol. Chem, 10.1074/jbc.M705325200
Submitted on June 28, 2007
Revised on August 17, 2007
Accepted on August 17, 2007
The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor
Eric L. Greer, Philip R. Oskoui, Max R. Banko, Jay M. Maniar, Melanie P. Gygi, Steven P. Gygi, and Anne Brunet
Department of Genetics, Stanford University, Stanford, CA 94306
Corresponding Author: anne.brunet{at}stanford.edu
The maintenance of homeostasis throughout an organisms lifespan requires constant adaptation to changes in energy levels. The AMP-activated protein kinase (AMPK) plays a critical role in the cellular responses to low energy levels by switching off energy-consuming pathways and switching on energy-producing pathways. However, the transcriptional mechanisms by which AMPK acts to adjust cellular energy levels are not entirely characterized. Here, we find that AMPK directly regulates mammalian FOXO3, a member of the FOXO family of Forkhead transcription factors known to promote resistance to oxidative stress, tumor suppression, and longevity. We show that AMPK phosphorylates human FOXO3 at six previously unidentified regulatory sites. Phosphorylation by AMPK leads to the activation of FOXO3 transcriptional activity without affecting FOXO3 subcellular localization. Using a genome-wide microarray analysis, we identify a set of target genes that are regulated by FOXO3 when phosphorylated at these six regulatory sites in mammalian cells. The regulation of FOXO3 by AMPK may play a crucial role in fine-tuning gene expression programs that regulate energy balance and stress resistance in cells throughout life.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Weidinger, K. Krause, A. Klagge, S. Karger, and D. Fuhrer
Forkhead box-O transcription factor: critical conductors of cancer's fate
Endocr. Relat. Cancer,
December 1, 2008;
15(4):
917 - 929.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Catoire, M. Y. Pasco, A. Abu-Baker, S. Holbert, C. Tourette, B. Brais, G. A. Rouleau, J. A. Parker, and C. Neri
Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1
Hum. Mol. Genet.,
July 15, 2008;
17(14):
2108 - 2117.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. B. Taylor, D. An, H. F. Kramer, H. Yu, N. L. Fujii, K. S. C. Roeckl, N. Bowles, M. F. Hirshman, J. Xie, E. P. Feener, et al.
Discovery of TBC1D1 as an Insulin-, AICAR-, and Contraction-stimulated Signaling Nexus in Mouse Skeletal Muscle
J. Biol. Chem.,
April 11, 2008;
283(15):
9787 - 9796.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. L. Greer and A. Brunet
Signaling networks in aging
J. Cell Sci.,
February 15, 2008;
121(4):
407 - 412.
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|